RE: RE: RE: RE: lots of noise When they are noticably "absent" means they aren't there !!
That means they know something SBM doesn't....it could be several things :
- The SGLT2 is not going to get to market in time to beat patent versus profitability
- other type of drugs ( better than SGLT2's) are being looked at.
- Stem cell therapy is being looked at with "farmed" stem cells.
- To much investment to chase J and J
Novo Nordisk has Victoza the "perfect" addition to this type of therapy.... and their absent.
Regardless, good luck and pick you battles !
E-mail if you want to talk over the phone.
JMHO